Research Topics
| Ulrich R MuellerSummaryCountry: Switzerland Publications
|
Detail Information
Publications
IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergyU Muller
Division of Allergy, Department of Medicine, Spital Ziegler, Bern, Switzerland
Allergy 67:1069-73. 2012..Component-resolved analysis with recombinant species-specific major allergens (rSSMA) may help to distinguish true double sensitization from crossreactivity...
Hymenoptera venom proteins and peptides for diagnosis and treatment of venom allergic patientsUlrich R Müller
Allergy Division, Medical Department, Spital Ziegler, Spital Netz Bern, Switzerland
Inflamm Allergy Drug Targets 10:420-8. 2011..Most clinical studies suggest an antiinflammatory effect as well, but are uncontrolled. The only few controlled studies could not confirm efficacy of treatment with bee venom so far...
Insect venomsUlrich R Müller
Spital Ziegler, Bern, Switzerland
Chem Immunol Allergy 95:141-56. 2010..Frequent cross-reactions to venoms of different Hymenoptera species may cause difficulties in identifying the responsible species and the selection of the respective venom for immunotherapy...
The problem of anaphylaxis and mastocytosisUlrich R Müller
Allergy Division, Department of Medicine, Spital Ziegler, Spitalnetzbern, Bern, Switzerland
Curr Allergy Asthma Rep 9:64-70. 2009..In mastocytosis patients with anaphylaxis due to Hymenoptera stings, venom immunotherapy is recommended for life...
Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapyUlrich R Müller
Medizinische Klinik, Spital Ziegler, Bern, Switzerland
J Allergy Clin Immunol 122:1001-1007.e4. 2008..H1 antihistamines increase safety during allergen-specific immunotherapy and might influence the outcome because of immunoregulatory effects...
[Hymenoptera venom anaphylaxis and cardiovascular disease]U R Muller
Allergiestation der Medizinischen Klinik, Spital Ziegler, Spitalnetz Bern, Bern, Schweiz
Hautarzt 59:206, 208-11. 2008..It may however, especially following rapid intravenous administration, cause severe arrhythmias or myocardial infarction. Adrenaline should therefore preferably be given intramuscularly, or by slow intravenous infusion...
Cardiovascular disease and anaphylaxisUlrich R Mueller
Department of Medicine, Zieglerspital, Bern, Switzerland
Curr Opin Allergy Clin Immunol 7:337-41. 2007..In severe anaphylaxis, the cardiovascular system is often heavily involved. Preexisting cardiovascular disease may therefore influence the course of anaphylaxis in a negative way...
Use of beta-blockers during immunotherapy for Hymenoptera venom allergyUlrich R Müller
Medical Department, Spital Bern Ziegler, Switzerland
J Allergy Clin Immunol 115:606-10. 2005..Immunotherapy is the best available treatment for prevention of life-threatening anaphylaxis to Hymenoptera stings, which is often observed in elderly patients who have cardiovascular disease and therefore are on beta-blocker treatment...
Recent developments and future strategies for immunotherapy of insect venom allergyUlrich R Müller
Medical Department, Spital Bern Ziegler, Bern, Switzerland
Curr Opin Allergy Clin Immunol 3:299-303. 2003..New strategies to improve safety and efficacy of this treatment are therefore of general interest...
Bee venom allergy in beekeepers and their family membersUlrich R Müller
Medical Department, Spital Bern Ziegler, Bern, Switzerland
Curr Opin Allergy Clin Immunol 5:343-7. 2005..To analyze prevalence of allergic sting reactions, including the clinical and diagnostic features as well as management options in a population heavily exposed to honeybee stings such as beekeepers and their family members...
